https://scholars.lib.ntu.edu.tw/handle/123456789/582161
標題: | To genotype or not to genotype: Toward an optimal tailoring of treatment of chronic hepatitis B [3] | 作者: | Lin C.-. JIA-HORNG KAO |
公開日期: | 2007 | 卷: | 44 | 期: | 12 | 起(迄)頁: | 1665-1666 | 來源出版物: | Clinical Infectious Diseases | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-34249892208&doi=10.1086%2f518386&partnerID=40&md5=96b92691335c553f23165cd07037f332 https://scholars.lib.ntu.edu.tw/handle/123456789/582161 |
ISSN: | 1058-4838 | DOI: | 10.1086/518386 | SDG/關鍵字: | hepatitis B(e) antigen; interferon; peginterferon; ribavirin; Chinese; chronic hepatitis; cost effectiveness analysis; drug efficacy; drug megadose; genotype; hepatitis B; Hepatitis B virus; human; letter; low drug dose; nonhuman; priority journal; Taiwan; treatment duration; treatment response; virus carrier; Antiviral Agents; DNA, Viral; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon Alfa-2a; Male; Polyethylene Glycols; Prognosis; Treatment Outcome |
顯示於: | 臨床醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。